跳至主要内容
临床试验/CTRI/2020/01/022895
CTRI/2020/01/022895尚未招募1 期

A Randomized controlled clinical study of Aamalakiawaleham and Dadimadighritam in the management of Pandu.

CARC Nigdi Pune0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients having lakshanas of Pandu.
  • Patients having Hb% between 7 to 11%.

排除标准

  • Mrudbhakshanjanya & Garbhini pandu.
  • Pandu associated with other chronic disprders like liver cirrhosis, ascitis, CCF,alcoholic liver diseases, HIV etc.
  • Patients with Updrava of Pandu.
  • Any type of malignant diseases e.g. Leukaemia metastatic cancer etc.
  • Acute Heamorrhagical and infectious condition.
  • Patient taking treatment from any other pathy for the same problem.
  • Known patients of DM.

研究者

发起方
CARC Nigdi Pune

相似试验